Evidence mapPaperPMID 41366350Full record

ArticleBMC endocrine disorders2025

Prevalence and associated factors of peripheral neuropathy in individuals with type 2 diabetes mellitus: a cross-sectional study in Khartoum State.

AlaaAldeen Makki Mohamed Ali, Mazin Yousif Babiker, Habab Khalid Elkheir, Ali Awadallah Saeed, Nadia Al Mazrouei, Sami Fatehi Abdalla, Anas Ali Alhur, Abdulaziz Alqadi, Abdullah S Alghamdi, Safaa Badi and 1 more

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

AlaaAldeen Makki Mohamed AliDepartment of Pharmacology and Pharmacy Practice, Faculty of Pharmacy, Karary University, Khartoum, Sudan.ORCID https://orcid.org/0000-0002-9295-6338
Mazin Yousif BabikerPharmacology and Toxicology Department, International University of Africa, Khartoum, Sudan.
Habab Khalid ElkheirDepartment of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University and University of Science and Technology, Khartoum, Sudan.
Ali Awadallah SaeedDepartment of Pharmacology, Faculty of Clinical and Industrial Pharmacy, National University-Sudan, Mycetoma Research Center, Khartoum, Sudan. alimhsd@gmail.com.ORCID https://orcid.org/0000-0003-3524-4825
Nadia Al MazroueiDepartment of Pharmacy Practice and Pharmacotherapeutics, Faculty of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-1339-9730
Sami Fatehi AbdallaDepartment of Clinical Sciences, College of Medicine, Almaarefa University, AlMaarefa University, Diriyah, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-7396-8376
Anas Ali AlhurDepartment of Health Information Management and Technology, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.ORCID https://orcid.org/0000-0001-6044-7072
Abdulaziz AlqadiAcute Care Pharmacy, Security Forces Hospital, Riyadh, 11481, Saudi Arabia.
Abdullah S AlghamdiMOI-Clinics, Security Forces Hospital, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-7911-6895
Safaa BadiDepartment of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan.ORCID http://orcid.org/0000-0003-3204-983X
Mohamed H AhmedDepartment of Medicine for Older people and Department of Diabetes, Warrington and Halton Teaching Hospitals NHS foundation Trust, Warrington, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic peripheral neuropathy (DPN) is a common and costly complication that occurs in both Type 1 and Type 2 diabetes mellitus. The prevalence of neuropathy is estimated to be around 8% in newly diagnosed patients and exceeds 50% in those with long-standing disease. The aim of this study was to determine the prevalence of DPN among individuals with Type 2 diabetes mellitus in Sudan and to identify the factors associated with DPN. METHODOLOGY: This cross-sectional study was conducted in the outpatient setting of an endocrinology clinic at a tertiary care centre (Diabetes Specialized Centres) in Khartoum State between January 2020 and January 2021.

resultsOut of the 236 patients included in the study, the mean age was 55.7 ± 11.5 years, and 54.7% were female. The prevalence of DPN was found to be 43%. Logistic regression analysis revealed that the following factors were significantly associated with DPN: body mass index (BMI) (P = 0.022, OR = 3.733), male gender (P = 0.003, OR = 7.165), educational level (P = 0.034, OR = 20.577), duration of diabetes (P = 0.014, OR = 13.121), age (P = 0.001, OR = 2.735), HbA1c level (P = 0.002, OR = 1.782), alcohol consumption (P = 0.000, OR = 212.158), smoking status (P = 0.005, OR = 0.063), and the presence of hypertension (P = 0.001, OR = 11.493).

conclusionThere a relatively high prevalence of DPN in the diabetic population of Sudan, and significantly associated with the duration of diabetes, BMI, age, HbA1c levels, male gender, alcohol consumption, smoking status, and hypertension. Regular screening and patient education are needed to reduce DPN in Sudanese patients with diabetes. CLINICAL TRIAL NUMBER: NA.

Indexed as

Diabetes Mellitus, Type 2Diabetic NeuropathiesAdultAgedBody Mass IndexCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedPrevalencePrognosisRisk FactorsSudanCross-sectional studyDiabetic neuropathyPrevalenceRisk factorType 2 diabetes mellitus

Identifiers

PMID41366350
PMCPMC12794461

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.